Latest news with #THV
Mint
5 hours ago
- Business
- Mint
ADIA to Invest USD 200 Million in Meril
Vapi, India– [21 July 2025] – A wholly owned subsidiary of the Abu Dhabi Investment Authority ('ADIA') has entered into definitive agreements to invest USD 200 million for a ~3% stake in Micro Life Sciences Private Limited ('Meril'), one of India's leading medical devices companies. This investment values Meril at an enterprise value of USD 6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this investment, Meril will be backed by two globally recognized investors, ADIA and Warburg Pincus. Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specialties — including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics and Surgical Robotics. Headquartered in Vapi, India, Meril operates state-of-the-art, vertically integrated, and globally certified manufacturing and R&D facilities, across a 100 acre sustainable MedTech campus. The company employs more than 13,000 people, has 35+ global subsidiaries, and serves healthcare systems in 150+ countries. Meril is committed to becoming the world's leading MedTech company, powered 100% by green energy, reinforcing its commitment to sustainable innovation. Meril With a robust in-house global R&D ecosystem and a portfolio of 200+ technology platforms, Meril continues to lead in global clinical research and education. Breakthrough innovations such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System highlight Meril's dedication to next-generation innovation. Through its 12+ global training academies, Meril empowers over 10,000 healthcare professionals annually. Sanjeev Bhatt, Senior Vice President – Strategy, Meril said: 'This investment by ADIA reinforces confidence in Meril's long term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Meril is a global medical technology company headquartered in Vapi, India. With a strong emphasis on innovation, Meril develops clinically meaningful products aimed at enhancing patient outcomes across cardiovascular, orthopaedic, diagnostic, Endo Surgery and robotic surgery domains. Founded by the Bilakhia Group, the company is committed to sustainability, quality, and global impact. For more information: About Abu Dhabi Investment Authority (ADIA) Established in 1976, the Abu Dhabi Investment Authority ('ADIA') is a globally-diversified investment institution that prudently invests funds on behalf of the Government of Abu Dhabi through a strategy focused on long-term value creation. For more information: Media contact :media@ Note to readers: This article is part of Mint's paid consumer connect Initiative. Mint assumes no editorial involvement or responsibility for errors, omissions, or content accuracy. Want to get your story featured as above?click here!
Hans India
5 hours ago
- Business
- Hans India
ADIA to Invest USD 200 Million in Meril
Vapi -- A wholly owned subsidiary of the Abu Dhabi Investment Authority ('ADIA') has entered into definitive agreements to invest USD 200 million for ~3% stake in Micro Life Sciences Private Limited ('Meril'), one of India's leading medical devices companies. This investment values Meril at an enterprise value of USD 6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this investment, Meril will be backed by two globally recognized investors, ADIA and Warburg Pincus. Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specialties — including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics and Surgical Robotics. Headquartered in Vapi, India, Meril operates state-of-the-art, vertically integrated, and globally certified manufacturing and R&D facilities, across a 100-acre sustainable MedTech campus. The company employs more than 13,000 people, has 35+ global subsidiaries, and serves healthcare systems in 150+ countries. Meril is committed to becoming the world's leading MedTech company, powered 100% by green energy, reinforcing its commitment to sustainable innovation. With a robust in-house global R&D ecosystem and a portfolio of 200+ technology platforms, Meril continues to lead in global clinical research and education. Breakthrough innovations such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System highlight Meril's dedication to next-generation innovation. Through its 12+ global training academies, Meril empowers over 10,000 healthcare professionals annually. Sanjeev Bhatt, Senior Vice President – Strategy, Meril said: 'This investment by ADIA reinforces confidence in Meril's long term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our RCD and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.'
Al Etihad
9 hours ago
- Business
- Al Etihad
ADIA to invest $200 million in Indian medical devices company
21 July 2025 11:27 A. SREENIVASA REDDY (ABU DHABI)A wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) has entered into a definitive agreement to invest $200 million for a 3% stake in Micro Life Sciences Private Limited (Meril), one of India's leading medical devices companies. This investment, which values Meril at an enterprise value of $6.6 billion, was confirmed in separate statements issued by both ADIA and transaction is subject to regulatory approval by India's Competition Commission. Once completed, it will result in Meril being backed by two globally recognised investors: ADIA and Warburg by the Bilakhia Group, Meril is headquartered in Vapi, in Gujarat province of India, and is a global innovator in the medical technology space. The company focuses on clinically advanced solutions across key healthcare domains, including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics, and surgical operations span more than 150 countries and are supported by a network of 35+ global subsidiaries. Its vertically integrated and globally certified manufacturing and research facilities are spread across a 100-acre sustainable MedTech campus. Employing over 13,000 people, Meril powers its operations entirely with green energy and runs more than 12 global training academies that reach over 10,000 healthcare professionals product innovations include the Myval Transcatheter Heart Valve (THV) series, the MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System. The company holds a portfolio of over 200 technology platforms and maintains a strong in-house ecosystem for global research, clinical trials, and on the deal, Sanjeev Bhatt, Senior Vice President – Strategy at Meril, said, 'This investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our RCD and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Established in 1976, ADIA is a globally diversified investment institution that prudently invests funds on behalf of the Government of Abu Dhabi through a strategy focused on long‑term value creation.
Fashion Value Chain
a day ago
- Business
- Fashion Value Chain
ADIA to Invest USD 200 Million in Meril
A wholly owned subsidiary of the Abu Dhabi Investment Authority ('ADIA') has entered into definitive agreements to invest USD 200 million for a ~3% stake in Micro Life Sciences Private Limited ('Meril'), one of India's leading medical devices companies. This investment values Meril at an enterprise value of USD 6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this investment, Meril will be backed by two globally recognized investors, ADIA and Warburg Pincus. ADIA to invest USD 200 million in Meril, valuing the Indian medical devices company at an enterprise value of USD 6.6 billion Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specialties – including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics and Surgical Robotics. Headquartered in Vapi, India, Meril operates state-of-the-art, vertically integrated, and globally certified manufacturing and RCD facilities, across a 100 acre sustainable MedTech campus. The company employs more than 13,000 people, has 35+ global subsidiaries, and serves healthcare systems in 150+ countries. Meril is committed to becoming the world's leading MedTech company, powered 100% by green energy, reinforcing its commitment to sustainable innovation. With a robust in-house global RCD ecosystem and a portfolio of 200+ technology platforms, Meril continues to lead in global clinical research and education. Breakthrough innovations such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System highlight Meril's dedication to next-generation innovation. Through its 12+ global training academies, Meril empowers over 10,000 healthcare professionals annually. Sanjeev Bhatt, Senior Vice President – Strategy, Meril said: 'This investment by ADIA reinforces confidence in Meril's long term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our RCD and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.'
Hindustan Times
27-05-2025
- Climate
- Hindustan Times
Who is Ed Buckner, Little Rock meteorologist who passed away after battle with cancer?
Former THV11 Chief Meteorologist Ed Buckner passed away at the age of 59, after a battle with cancer. Buckner was a popular face in the Arkansas weather coverage circle for decades and has been a trusted source of weather predictions and analysis for Arkansans during severe weather events. Some of his monumental weather coverage includes the infamous 1999 tornado outbreak. ALSO READ| Who is Yaqeen Hammad? Gaza's 'youngest influencer' reportedly killed by Israeli airstrike Buckner was a part of popular channel THV11 for nearly 25 years, and his colleagues admired his commitment and dedication towards work, apart from being a great mentor and a kind-hearted friend. Buckner was also a musician and had even released a children-friendly weather album. 'Ed was such a sharp, polite gentleman and so talented in so many ways. He left us too soon,' KATV Chief Meteorologist Barry Brandt was quoted as saying after news of Buckner's death reached the office. ALSO READ | New footage emerges from The Titan's expedition to Titanic wreckage, implosion heard 'Ed was so kind. He gave me my first start in TV — back in 2004. THV had a summer Kidcaster campaign and I was selected to do weather one evening that summer. It was an incredible experience that shaped me at just 10 years old, and it put me on a path to a TV career in this market 15 years later,' KATV Meteorologist James Bryan said. 'So sad to hear the news of Ed Buckner's passing. Although we were local television competitors, it was always a friendly competition between us. I am only wishing his family peace at this difficult time,' Chief Meteorologist Ned Perme was quoted as saying, according to a KATV report. Bucker is currently survived by his wife, four children, and seven grandchildren.
